Screener
Journey Medical Corporation DERM Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Journey Medical Corporation’s 10-Q, filed August 12, 2026.
- Filed
- Aug 12, 2026, 4:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-094948
| Line item | Three-Month Periods Ended / June 30, 2026 | Three-Month Periods Ended / June 30, 2025 | Six-Month Periods Ended / June 30, 2026 | Six-Month Periods Ended / June 30, 2025 |
|---|---|---|---|---|
| Total other expense | 753 | 860 | 1,491 | 1,609 |
| Loss before income taxes | (297) | (3,736) | (2,527) | (7,809) |
| Income tax expense | 15 | 60 | 15 | 60 |
| Net loss | $(312) | $(3,796) | $(2,542) | $(7,869) |
| Net loss per common share: | ||||
| Basic and diluted | $(0.01) | $(0.16) | $(0.09) | $(0.34) |
| Weighted average number of common shares: | ||||
| Basic and diluted | 27,493,693 | 23,290,806 | 27,399,881 | 22,952,801 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Journey Medical Corporation's net income?
- Journey Medical Corporation (DERM) reported net income of -$312K in Q2 2026.
- How has Journey Medical Corporation's net income changed year-over-year?
- Journey Medical Corporation's net income increased by 91.8% year-over-year, from -$3.8M to -$312K.
- What is the long-term trend for Journey Medical Corporation's net income?
- Over 3 years (2021 to 2025), Journey Medical Corporation's net income has grown at a -36.2% compound annual growth rate (CAGR), from -$43.99M to -$11.43M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Journey Medical Corporation's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude